- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07562750
Empowered Relief Study
Empowered Relief for Osteoarthritis (OA)
"Empowered Relief" (ER) Intervention was developed by Beth Darnall, PhD at what is now the Stanford Pain Relief Innovations Lab. Our design is a randomized 3-arm study with test treatment, active control, and placebo arms. Our goals are to provide scientific evidence to demonstrate the efficacy of ER, and also provide a comparison of said efficacy against the standard of care - group pain-CBT. Treatment allocation is randomized to minimize confounder effects. Statisticians performing analyses will be blinded.
The primary objective of this study is to evaluate the efficacy of Empowered Relief (a novel, single-session (2-hour), evidence-based online pain management class) on reducing pain burden and improving quality of life in patients with advanced osteoarthritis. Empowered Relief is designed to compress key cognitive behavioral therapy (CBT) skills, mindfulness principles, and pain neuroscience education into a brief, scalable format.
Specifically, the study aims to: Evaluate Clinical Outcomes: Determine whether the intervention reduces pain burden and enhances mobility.
Assess Psychological & Behavioral Impact: Examine whether the intervention improves patient-reported understanding of pain, fosters self-efficacy, and increases perceived control, thereby promoting active engagement in their own pain management.
Subject Population: The subject population consists of adult patients diagnosed with advanced osteoarthritis (KL Grade 3-4) who have been deferred from total hip or total knee arthroplasty (THA/TKA). Deferment criteria for this population include existing medical, surgical, behavioral, or personal barriers that currently preclude them from undergoing joint replacement surgery. This population is particularly vulnerable to prolonged suffering, decreased mobility, and compounding psychosocial distress while managing severe somatic pain without immediate surgical options.
Main Research Procedures: The study will utilize a prospective, longitudinal design to measure the impact of the Empowered Relief intervention on the target population.
The main procedures include: Intervention Delivery: Eligible participants will complete the live Empowered Relief online class (via Zoom) with a certified instructor (Dr. Caryn Lindsey), a 2-hour intervention equipping them with accessible, evidence-based behavioral pain management skills.
Data Collection Schedule: Participants will be assessed at three distinct time points: Baseline (pre-intervention), 4-weeks post-treatment, and 8-weeks post-treatment.
연구 개요
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Jordan Bernstein
- 전화번호: 5514973176
- 이메일: jordan.bernstein@cshs.org
연구 장소
-
-
California
-
Los Angeles, California, 미국, 90048
- Cedars Sinai
-
연락하다:
- Jordan Bernstein
- 전화번호: 551-497-3176
- 이메일: jordan.bernstein@cshs.org
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
설명
Inclusion Criteria:
- Adults age 18 or older who are eligible and interested in enrolling
Exclusion Criteria:
- Any records flagged "break the glass" or "research opt out"
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Test Treatment
|
2-hour pain management course
|
|
활성 비교기: Educational Materials
Patients will be provided with a handout from the U.S. Pain Foundation titled "Self Management Strategies"
|
"Self Management Strategies" is an educational handout from the US Pain Foundation
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Pain Catastrophizing Scale (PCS)
기간: Once at baseline, then at weeks 2, 4, 8, and 12.
|
Once at baseline, then at weeks 2, 4, 8, and 12.
|
|
|
NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Measures
기간: Once at baseline, then at weeks 2, 4, 8, and 12
|
Questions related to pain, physical function, and depression.
|
Once at baseline, then at weeks 2, 4, 8, and 12
|
|
Pain Self-Efficacy Questionnaire
기간: Once at baseline, then at weeks 2, 4, 8, and 12
|
Once at baseline, then at weeks 2, 4, 8, and 12
|
공동 작업자 및 조사자
간행물 및 유용한 링크
일반 간행물
- 3. Wertli, M.M., et al., The Influence of Catastrophizing on Treatment Outcome in Patients With Non-Specific Low Back Pain: A Systematic Review. Spine (Phila Pa 1976), 2013.
- 2. CDC, Prevalence and Most Common Causes of Disability Among Adults --- United States, 2005. MMWR, 2009. 58(16): p. 421-416.
- 1. Freburger, J.K., et al., The rising prevalence of chronic low back pain. Arch Intern Med, 2009. 169(3): p. 251-8.
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .